187.25
price up icon0.14%   0.26
after-market 시간 외 거래: 187.25
loading
전일 마감가:
$186.99
열려 있는:
$186.9
하루 거래량:
5.33M
Relative Volume:
0.69
시가총액:
$330.76B
수익:
$57.37B
순이익/손실:
$4.20B
주가수익비율:
79.68
EPS:
2.35
순현금흐름:
$15.39B
1주 성능:
+0.82%
1개월 성능:
-5.65%
6개월 성능:
+3.17%
1년 성능:
+16.89%
1일 변동 폭
Value
$184.82
$188.73
1주일 범위
Value
$182.37
$188.73
52주 변동 폭
Value
$159.77
$218.66

애브비 Stock (ABBV) Company Profile

Name
명칭
Abbvie Inc
Name
전화
(847) 932-7900
Name
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Name
직원
55,000
Name
트위터
@abbvie
Name
다음 수익 날짜
2025-04-25
Name
최신 SEC 제출 서류
Name
ABBV's Discussions on Twitter

ABBV을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
ABBV
Abbvie Inc
187.25 328.06B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
LLY
Lilly Eli Co
750.78 651.06B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
154.42 368.73B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
115.94 223.60B 53.22B 12.86B 14.85B 6.39
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
70.91 312.99B 43.59B 15.04B 10.74B 3.3766

애브비 Stock (ABBV) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-14 다운그레이드 Citigroup Buy → Neutral
2025-04-22 개시 Cantor Fitzgerald Overweight
2024-12-10 재개 BofA Securities Neutral
2024-12-05 다운그레이드 Daiwa Securities Outperform → Neutral
2024-11-22 업그레이드 Leerink Partners Market Perform → Outperform
2024-11-15 개시 Wolfe Research Outperform
2024-11-04 업그레이드 Argus Hold → Buy
2024-10-17 개시 Bernstein Mkt Perform
2024-06-05 업그레이드 HSBC Securities Hold → Buy
2024-05-17 개시 Cantor Fitzgerald Overweight
2024-01-29 업그레이드 William Blair Mkt Perform → Outperform
2023-12-18 다운그레이드 HSBC Securities Buy → Hold
2023-12-11 업그레이드 Goldman Neutral → Buy
2023-11-09 개시 Deutsche Bank Hold
2023-10-30 업그레이드 Barclays Equal Weight → Overweight
2023-10-20 재개 UBS Neutral
2023-09-29 개시 Raymond James Outperform
2023-07-25 개시 William Blair Mkt Perform
2023-07-14 개시 HSBC Securities Buy
2023-04-05 다운그레이드 Argus Buy → Hold
2023-03-01 개시 Guggenheim Buy
2023-02-22 다운그레이드 Wolfe Research Outperform → Peer Perform
2023-02-10 업그레이드 SVB Securities Underperform → Market Perform
2022-11-18 개시 Credit Suisse Outperform
2022-11-08 다운그레이드 Societe Generale Buy → Hold
2022-08-01 다운그레이드 Atlantic Equities Overweight → Neutral
2022-05-23 개시 SVB Leerink Underperform
2022-05-06 다운그레이드 Daiwa Securities Outperform → Neutral
2022-04-06 재개 Morgan Stanley Overweight
2022-02-28 다운그레이드 UBS Buy → Neutral
2022-02-03 재확인 BMO Capital Markets Outperform
2022-02-03 재확인 Barclays Equal Weight
2022-02-03 재확인 BofA Securities Neutral
2022-02-03 재확인 Goldman Neutral
2022-01-13 개시 Redburn Buy
2022-01-12 재확인 BMO Capital Markets Outperform
2021-12-09 재개 Wells Fargo Overweight
2021-11-23 업그레이드 Societe Generale Hold → Buy
2021-07-27 재개 Truist Buy
2021-04-07 재개 RBC Capital Mkts Outperform
2020-11-10 재개 Bernstein Outperform
2020-09-29 개시 Berenberg Hold
2020-06-23 업그레이드 Atlantic Equities Neutral → Overweight
2020-06-09 업그레이드 Wolfe Research Peer Perform → Outperform
2020-06-02 업그레이드 Argus Hold → Buy
2020-05-18 재개 BofA/Merrill Neutral
2020-05-12 업그레이드 JP Morgan Neutral → Overweight
2020-05-11 재개 Morgan Stanley Overweight
2020-04-20 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2020-03-23 다운그레이드 Societe Generale Buy → Hold
2020-02-27 개시 Barclays Equal Weight
2020-02-06 개시 Mizuho Buy
2020-01-07 개시 RBC Capital Mkts Sector Perform
2019-12-26 재확인 Cowen Outperform
2019-09-26 업그레이드 Citigroup Neutral → Buy
2019-08-20 업그레이드 Piper Jaffray Neutral → Overweight
2019-06-27 업그레이드 Wolfe Research Underperform → Peer Perform
2019-06-26 업그레이드 SVB Leerink Mkt Perform → Outperform
2019-05-28 개시 Goldman Neutral
2019-04-29 업그레이드 BMO Capital Markets Underperform → Market Perform
모두보기

애브비 주식(ABBV)의 최신 뉴스

pulisher
02:22 AM

ABBV: Bullish Momentum Evident in AbbVie Options Activity | ABBV Stock News - GuruFocus

02:22 AM
pulisher
01:53 AM

AbbVie call volume above normal and directionally bullish - TipRanks

01:53 AM
pulisher
12:09 PM

ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons - Yahoo Finance

12:09 PM
pulisher
08:51 AM

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - Investing News Network

08:51 AM
pulisher
08:30 AM

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals | ABBV Stock News - GuruFocus

08:30 AM
pulisher
08:17 AM

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference | ABBV Stock News - GuruFocus

08:17 AM
pulisher
08:15 AM

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals - PR Newswire

08:15 AM
pulisher
Jun 02, 2025

Immunology Market Deep Research Report Signals Rapid GrowthAbbVie Inc., Johnson & Johnson - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Meta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades' - Benzinga

Jun 02, 2025
pulisher
May 31, 2025

How Is AbbVie's Stock Performance Compared to Other Pharmaceuticals Stocks? - MSN

May 31, 2025
pulisher
May 31, 2025

AbbVie Inc. (ABBV) and Chicago Cubs Launch “Striking Out Cancer” Campaign - Insider Monkey

May 31, 2025
pulisher
May 31, 2025

AbbVie announces multi-year partnership with the Chicago Cubs - TipRanks

May 31, 2025
pulisher
May 30, 2025

AbbVie (ABBV) Gains As Market Dips: What You Should Know - Yahoo Finance

May 30, 2025
pulisher
May 30, 2025

Final Trades: JPMorgan, Meta, Abbvie and Gap - CNBC

May 30, 2025
pulisher
May 30, 2025

AbbVie (ABBV) Partners with Chicago Cubs for Cancer Awareness Initiative | ABBV Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

AbbVie Partners with Chicago Cubs on "Striking Out Cancer" | ABB - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV)June 3, 2025 Deadline to Join – Contact Levi & Korsinsky - TradingView

May 30, 2025
pulisher
May 30, 2025

AbbVie’s ADC win shows how pharma can break through in solid tumors - Pharma Voice

May 30, 2025
pulisher
May 30, 2025

AbbVie (ABBV) Stock Dips in Morning Trade: What Key Numbers Reveal - Daily Chhattisgarh News

May 30, 2025
pulisher
May 30, 2025

Analyst recommendations: AbbVie, Emerson Electric, Marriott International, Zscaler, and Monster Beverage… - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

AbbVie Partners with Chicago Cubs on "Striking Out Cancer" - PR Newswire

May 30, 2025
pulisher
May 30, 2025

How Is AbbVie's Stock Performance Compared To Other Pharmaceuticals Stocks? - Barchart.com

May 30, 2025
pulisher
May 30, 2025

Berenberg Adjusts Price Target on AbbVie to $170 From $195, Maintains Hold Rating - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. LawsuitABBV - marketscreener.com

May 30, 2025
pulisher
May 29, 2025

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical - MSN

May 29, 2025
pulisher
May 29, 2025

Contact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Cerevel Therapeutics Holdings, Inc.(ABBV) - TradingView

May 29, 2025
pulisher
May 29, 2025

AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

AbbVie: Fairly Valued, But Lacking A Spark - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Cancer Therapeutics Market Is Booming So Rapidly 2025-2032 - openPR.com

May 29, 2025
pulisher
May 29, 2025

Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for InvestorsContact The Gross Law Firm - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Sarah Cannon Research Institute Announces Strategic Alliance with AbbVie to Advance Novel Cancer Therapies - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

CERE DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - GlobeNewswire Inc.

May 28, 2025
pulisher
May 28, 2025

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Bearish Sentiment and Increased Put Activity for AbbVie (ABBV) | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

AbbVie put volume heavy and directionally bearish - TipRanks

May 28, 2025
pulisher
May 28, 2025

Sarah Cannon Research Institute Announces Strategic Alliance With AbbVie to Advance Novel Cancer Therapies - BioSpace

May 28, 2025
pulisher
May 28, 2025

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? - sharewise

May 28, 2025
pulisher
May 28, 2025

Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers Squibb - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

AbbVie’s Allergan cuts over 200 staff after botched marketing campaign - PharmaLive

May 28, 2025
pulisher
May 28, 2025

AbbVie’s Allergan Cuts Over 200 Staff After Botched Marketing Campaign - BioSpace

May 28, 2025
pulisher
May 27, 2025

AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit - MSN

May 27, 2025
pulisher
May 27, 2025

AbbVie To Present Cancer Trial Data At Upcoming ASCO Event - Benzinga

May 27, 2025
pulisher
May 27, 2025

AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio - Investing News Network

May 27, 2025
pulisher
May 27, 2025

AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio | ABBV Stock News - GuruFocus

May 27, 2025
pulisher
May 26, 2025

Tissue Engineering Market Generated Opportunities, Future - openPR.com

May 26, 2025
pulisher
May 26, 2025

Prurigo Nodularis Market - GlobeNewswire Inc.

May 26, 2025
pulisher
May 26, 2025

AbbVie’s SWOT analysis: biopharma giant faces pipeline challenges amid stock growth - Investing.com

May 26, 2025
pulisher
May 26, 2025

Precision immunology Market Growth in Future Scope 2025-2032 | - openPR.com

May 26, 2025
pulisher
May 26, 2025

Immunomodulatory Drugs Market in 2025 Detailed Study Analysis | - openPR.com

May 26, 2025

애브비 (ABBV) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general JNJ
$154.42
price down icon 0.63%
drug_manufacturers_general NVS
$115.94
price down icon 0.65%
drug_manufacturers_general NVO
$70.91
price down icon 2.64%
drug_manufacturers_general MRK
$77.14
price up icon 1.17%
drug_manufacturers_general GSK
$40.46
price down icon 2.88%
자본화:     |  볼륨(24시간):